CAMBRIDGE, United Kingdom and LEXINGTON, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Transition Bio, a drug discovery company ...

Open-label prophylaxis data supporting the long-term safety profile and sustained benefits of deucrictibant, as well as clinical validation data of a kinin biomarker assay were highlighted in two oral ...

Abstract: The security tracking control problem is addressed for nonlinear discrete-time networked control systems (NCSs) subject to energy-constrained denial-of-service (EC-DoS) attacks. A ...